Malta - English - Medicines Authority

hospira uk limited - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/ml - antineoplastic agents

Malta - English - Medicines Authority

teva pharma b.v. swensweg 5, 2031 ga haarlem, netherlands - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/ml - antineoplastic agents

Malta - English - Medicines Authority

mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/ml - antineoplastic agents

Malta - English - Medicines Authority

cipla (eu) limited hillbrow house, hillbrow road, esher, surrey, kt10 9nw, united kingdom - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/ml - antineoplastic agents

Malta - English - Medicines Authority

cipla (eu) limited hillbrow house, hillbrow road, esher, surrey, kt10 9nw, united kingdom - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/ml - antineoplastic agents

Malta - English - Medicines Authority

cipla (eu) limited hillbrow house, hillbrow road, esher, surrey, kt10 9nw, united kingdom - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/ml - antineoplastic agents

Malta - English - Medicines Authority

teva pharma b.v. swensweg 5, 2031 ga haarlem, netherlands - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/ml - antineoplastic agents

Malta - English - Medicines Authority

teva pharma b.v. swensweg 5, 2031 ga haarlem, netherlands - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/ml - antineoplastic agents

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - cisplatin, quantity: 1 mg/ml - injection, solution - excipient ingredients: mannitol; water for injections; sodium chloride - cisplatin injection is indicated for the palliative treatment of metastatic non-seminomatous germ cell carcinoma, advanced-stage refractory ovarian carcinoma, advanced-stage refractory bladder carcinoma and refractory squamous cell carcinoma of the head and neck. it may be used as a single agent or in combination with other chemotherapeutic agents. it may be employed, in appropriate circumstances, in addition to other modalities, eg radiotherapy or surgery.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - cisplatin, quantity: 1 mg/ml - injection, solution - excipient ingredients: sodium chloride; mannitol; water for injections - cisplatin injection is indicated for the palliative treatment of metastatic non-seminomatous germ cell carcinoma, advanced-stage refractory ovarian carcinoma, advanced-stage refractory bladder carcinoma and refractory squamous cell carcinoma of the head and neck. it may be used as a single agent or in combination with other chemotherapeutic agents. it may be employed, in appropriate circumstances, in addition to other modalities, eg radiotherapy or surgery.